stockrowCardio Diagnostics Holdings, Inc. (CDIO) vs Imunon, Inc. (IMNN)
- Cardio Diagnostics Holdings, Inc. CDIO 1.65 −1.79%
- Imunon, Inc. IMNN 0.85 −5.56%
Cardio Diagnostics Holdings, Inc. and Imunon, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Imunon, Inc. are of similar size ($5.1M and $5.0M). Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −3.23%. Imunon, Inc. has the higher net margin (0.00% vs −42,429.2%) and the lower return on invested capital (−324.4% vs −228.0%). Across the 17 metrics below, Cardio Diagnostics Holdings, Inc. leads on 10 and Imunon, Inc. on 7.
Valuation
Profitability
| Metric | CDIO | IMNN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (42,356.17%) | 0.00% | 0.00% |
| Net margin | (42,429.24%) | 0.00% | 0.00% |
| Free cash flow margin | (37,817.51%) | 0.00% | 0.00% |
| Return on equity | (93.55%) | (641.02%) | (51.96%) |
| Return on assets | (87.24%) | (123.93%) | (46.06%) |
| Return on invested capital | (227.98%) | (324.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack